S
Sun Pharmaceuticals and Taro Pharmaceuticals
Direct purchasers of certain generic drugs may be eligible for compensation from an $85 million settlement resolving price-fixing claims.
ClosedUnited States-wideClaim status: Closed on May 6, 2024Payout: VariesNo longer claimable
About this settlement
Alleged price-fixing of generic pharmaceutical drugs sold directly to purchasers.
This settlement resolves claims that Sun Pharmaceuticals and Taro Pharmaceuticals conspired to raise and fix prices on certain generic drugs sold directly to purchasers between 2009 and 2019. Eligible direct purchasers may receive compensation by submitting a claim with proof of purchase.
Who qualifies
- Individuals or entities who purchased named generic drugs directly from the defendants.
- Purchases made between May 1, 2009 and Dec. 31, 2019.
- Must have proof of purchase such as receipts or prescription orders.
Varies
Claim status: Closed on May 6, 2024